ArticleMolecular therapy : the journal of the American Society of Gene Therapy2011

Adaptive antiviral immunity is a determinant of the therapeutic success of oncolytic virotherapy.

Paul T Sobol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.